drugset / Trial / NCT00516243
Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast Cancer
Phase 1
Completed
40 enrolled
National Cancer Institute (NCI)
National Institutes of Health (NIH) · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This randomized phase I trial studies the side effects and best dose of defined green tea catechin extract in treating women with hormone receptor-negative stage I-III breast cancer. Green tea extract contains ingredients that may prevent or slow the growth of breast cancer.
Timeline
- Start
- 2007-07
- Primary completion
- 2010-03
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sinecatechins | Unknown | 400 mg | Oral |
| Subject | Sinecatechins | Unknown | 600 mg | Oral |
| Subject | Sinecatechins | Unknown | 800 mg | Oral |